Health Care Technology

OneMedNet

OneMedNet released FY2026 Q1 earnings on May 15 (EST), actual revenue USD 96K, actual EPS USD -0.0443

OneMedNet released FY2025 Q4 earnings on March 30 (EST), actual revenue USD 891K, actual EPS USD -0.057

OneMedNet released FY2025 Annual Earnings on March 30 (EST), actual revenue USD 1.359 M, actual EPS USD -0.0628

OneMedNet Corporation Signs EEG Data License Agreement with Risorius

OneMedNet Corporation Delivers 1.5 Million Patient Dataset to a Medical Analytics Organization

Onemednet Corporation Director Submits Initial Beneficial Ownership Statement

OneMedNet Corporation Launches Redesigned Data Exploration and Cohort Building Platform

OneMedNet released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 469 K and EPS of USD 0.0021

OneMedNet released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 177K, actual EPS USD -0.014

OneMedNet Successfully Fulfills Its Revenue Model Promise by Offering Real-World Data Subscriptions

Palantir Signs AI and Data Analytics Collaboration Agreement with OneMedNet for Healthcare

OneMedNet released FY2025 Semi-Annual earnings on August 13, 2025, EST with actual revenue of USD 292 K and EPS of USD 0.027

OneMedNet released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 155K, actual EPS USD 0.072

OneMedNet Completes About $3.7 Million Private Placement and Reduces Debt

OneMedNet released FY2025 Q1 earnings on May 14 (EST), actual revenue USD 137K, actual EPS USD -0.0557

HealthVerity Integrates with OneMedNet to Expand Imaging Data Access

OneMedNet and Protege Partner to Advance AI-Driven Healthcare

OneMedNet released FY2024 Q4 earnings on April 15 (EST), actual revenue USD 26 K, actual EPS USD -0.0638

OneMedNet released FY2024 annual earnings on April 15, 2025 (EST), with actual revenue of USD 643 K and EPS of USD -0.3607

OneMedNet released FY2024 Q3 earnings on December 17 (EST), actual revenue USD 142 K, actual EPS USD -0.0703

Amesite

InMed Pharmaceuticals

Meiwu Tech

Co-Diagnostics

Phoenix Asia

Generation Income Properties

MetaVia

Rubico

BAYVIEW ACQUISITION CORPORATION COM USD0.0001 (S/R) 17/11/2028

Virax Biolabs

ONMD

Earnings Watch

OneMedNet | 10-Q: FY2026 Q1 Revenue: USD 96 K

ONMDW

LABU

SBIO

OneMedNet shares are trading higher after Form 4 filings showed that the CMO acquired over 1.1 million shares at an average price of $0.83 per share and a Director acquired over 8765,000 shares at an average price of $0.86 per share.

benzinga_article

ONEMEDNET CORP C/WTS 07/11/2028 (TO PUR COM)

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

ALPS Medical Breakthrough

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bear 3X

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 595,238 shares at $0.84 each, totaling $499,999.92, on February 6th. This acquisition increased his holdings to 16,380,429 shares, valued at approximately $13.76 million. The stock rose 24.1% to $1.10 during trading. Despite this, Weiss Ratings maintains a "sell (d-)" rating on the stock, which has a market cap of $57.58 million and a PE ratio of -15.76. Institutional investors own 0.95% of the company, which specializes in clinical imaging solutions.

Market Beat

Palantir Tech

State Street

Virtu Finc

State Street® US Equity Premium Inc ETF

Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires 595,238 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 280,898 shares at $0.89 each, totaling $249,999.22, on April 23rd. This acquisition increased his ownership by 1.71%, bringing his total to 16,661,327 shares valued at approximately $14.83 million. The transaction was disclosed to the SEC. The stock recently traded at $1.10, with a market cap of $57.58 million and a 52-week range of $0.31 to $4.22. Analysts maintain a "sell" rating on the stock, with institutional investors holding 0.95% of shares.

OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Buys 280,898 Shares

OneMedNet (ONMD) has received a notice from Nasdaq for non-compliance with the $1.00 minimum bid price requirement, as its stock traded below this threshold for 30 consecutive business days. The company has 180 days to raise its share price to at least $1.00 for ten consecutive trading days, with a possible extension. OneMedNet may consider options like a reverse stock split to regain compliance, but failure to meet Nasdaq requirements could lead to delisting, impacting liquidity and capital access. The company operates in healthcare and medical data technology, with a market cap of $46.04M.

Tip Ranks

OneMedNet Faces Nasdaq Non-Compliance Over Minimum Bid Price

PLTW

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | ONMD Stock News

StockTitan

Roundhill PLTR WeeklyPay ETF

SPDR S&P Software

Leverage Shares 2X Long PLTR Daily ETF

Leverage Shares 2x Cpd Acclrtd PLTRMnETF

iShares Expanded Tech Software Sector ETF

Direxion Daily PLTR Bull 2X Shares

GraniteShares 2x Long PLTR Daily ETF

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | ONMD Stock News

ONCO

OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | ONMD Stock News

Onconetix

Health Care Select Sector SPDR

iShares US Pharma

VG Health

Ark Genomic Revolution ETF

iShares Global Healthcare

OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | ONMD Stock News

OneMedNet(ONMD.US)

OneMedNet | 10-Q: FY2026 Q1 Revenue: USD 96 K

OneMedNet shares are trading higher after Form 4 filings showed that the CMO acquired over 1.1 million shares at an average price of $0.83 per share and a Director acquired over 8765,000 shares at an average price of $0.86 per share.

Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires 595,238 Shares of Stock

OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Buys 280,898 Shares

OneMedNet Faces Nasdaq Non-Compliance Over Minimum Bid Price

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | ONMD Stock News

OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | ONMD Stock News